Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I am not a real technician but it appears to me that Moderna along with the whole technology/growth group have turned this market around. Three days of big gains following the rally last Monday signal the end of the correction. Now we will see how the new rally goes. MRNA looks very strong now. Some short covering will only add to our gains!
It looks like the FDA has rejected the notions of our conspiracy minded associates. Data from all studies of the vaccine up to six months after the second dose confirms that it is safe and efficacious.
It also appears to me that todays market action is confirming a turnaround for technology and growth stocks. The Nasdaq blasted through 14,000 with big volume. This will be great news for Moderna and should signal a big recovery. That’s my opinion but I hear others saying Nasdaq could fall more. We will see.
Thanks for the link, Axel. It was a short, concise view of what to expect in coming years from Moderna. I expect they are correct in saying we will be getting an annual booster for COVID-19. A specific omicron booster will soon be available and these vaccine producers will stay in business with new variants . The unvaccinated people will continue to provide a large pool for producing new variants. The future is bright for Moderna.
I am close to buying calls for September. Short term calls are way to0 risky for me. Of course, I’m retired and I need the money to live on.
Don’t worry about today’s price. I believe that we are very close to turning this thing around. When it happens, we will be waaaaay above $160. This stock is ready to rebound in a big way. JMO of course.
MRNA is going to open higher this morning along with the whole market. This is a great sign but it is NOT confirmation that the correction is over. We hope it is over and a rally has begun but use a little caution. I personally think this is the beginning of a rally but will try to not react emotionally until there is further confirmation in coming days.
Congratulations on making money. Selling (short) at the top was a good move. Me, I sold 50% of my shares near the top ($460) and am holding the rest to make more money. It has worked for both of us………..so far.
Michael TRed still does not understand the stock market. He says, “ scams over.” Moderna will announce quarterly earnings on Feb 24. The consensus estimate is $9.54 and we know they have contracts through 2022. There is no scam. There is an amazingly profitable company changing the way medicines and vaccines are produced.
Obviously the company’s stock has been hammered over the past 3 months due to the meteoric rise in price before an earnings miss last quarter, exacerbated by a massive correction in the whole market. These events always lead to a recovery which may turn out to be quite dramatic……Don’t hold your breath; the recovery may happen tomorrow but could be a month or longer away.
I know we’re right Axel. The guys who think vaccines are a scam also are waiting in Dallas for the return of JFK and believe that Trump won the election in 2020. That is delusional thinking.
With all due respect, I have to acknowledge this stock has gone to hell but I do not agree with your belief that earnings will disappear or that the company is a scam. You are just dead wrong on that. We will hear about earnings and projected sales next month and will find that the company is still doing amazingly well. The whole world is buying the product. Most of the growth stocks in my portfolio have dropped precipitously in the past two months and MRNA was the most overvalued and has dropped the most. I can afford to ride it out and wait for recovery.
You guys can keep believing in all the scams ruining your lives.
IHuser, I think you mean more cardiologists were getting laid, not layed off pre Covid. Job security has been very good for cardiologists in my lifetime. My problem now is getting an appointment to see a cardiologist. They’re booked up for months in advance.
Thanks for the tire advice.
I reviewed some data recently and as I recall, the risk of developing myocarditis was much higher in young men infected with the Covid-19 virus than in those who were vaccinated. The risk of myocarditis in vaccinated young men was very low and is not “rising” as far as I know. I agree that it is a risk
As a physician, I have always taught that prevention is better than treatment. I really believe that and my experience is based on reality. A majority of cancers and heart disease can be prevented by lifestyle changes. I equate “failure to get COVID vaccination” with “smoking a pack of cigarettes a day.”
You can treat heart disease by cracking the chest open and diverting more blood into the coronary arteries. Or the person at risk can stop smoking, lose weight by eating a healthy diet, take a statin drug daily, exercise. He might have a heart attack at age 75 instead of age 45. That makes sense to most people. The evidence is overwhelming that a vaccination with Moderna or Pfizer vaccine will prevent serious disease, hospitalization and death. That makes sense to most people. Your position is not really sensible and is not based on valid observations IMO.
Thanks for posting the link from Nature, a reputable source of information. The article was written when the delta variant was spreading. I don’t know if they information provided in that piece applies to the omicron variant.
Of note is the last paragraph: “we think it is really, really important to get as many people double vaccinated….”
The author also emphasized the importance of vaccinated people wearing masks indoors. The science behind these recommendations made sense to me.
Now for MY OPINION ONLY: Covid is not likely to go away in the foreseeable future. Vaccination will be the most effective way to combat the virus. Vaccines will focus on the new prevalent variants each year. Companies like Moderna, Pfizer, BioNTech will continue to lead the way in production of new vaccines.
Earnings to be reported Feb 24. Consensus of 11 analysts: $8.96/share with high and low estimates of $10.85 and $5.25. Analysts missed badly last time so we’ll see.
And don’t look now but today looks like the breakout day for the stock. It hit a lower low than November ($215 compared to $225). Volume and price are soaring this morning. I am cautious and will wait till end of day to be sure. Looking at $225 calls for May or June.
It sounds like axelvento is bullish on Moderna stock even in the face of the BS thrown around my contributors to this board. I definitely agree with axel; this could be the Amazon of 2023-24. I’m not going to predict a price but the cash flow and potential of all the drugs in their pipeline is astounding. Let’s admit it: mRNA is changing the world of medicine (You could read that as “messenger RNA or MRNA) That’s what’s happening and it is crazy to bet against it.
MAYBE……….. I don’t think we can tell yet. I hope you are right but we need a few more days of trading to convince me.
Absolutely! The biggest complaint I have heard is that it is overvalued at a market cap of $87 Billion. But it actually is selling at a forward P/E of 8.3. It seems to me to be way undervalued. Price has to go up, waaaay up! IMO
Still too early to call a bottom for MRNA. I’m hoping that $215 was the bottom but we need another day or two to see where its going. When I see a substantial increase in price with higher volume, I’m going to check on call prices. I would like to ride the price up a hundred bucks or so with some low cost calls. I think that will be possible. JMO of course.
Hurray for ofspring. He finally made an accurate statement. (Other than the adjective used to describe a fine company). MRNA has fallen below support level. We don’t know if he is correct that it will continue to fall. It will either start a recovery, or end even lower today and fall to a new support level. Time will tell. Holding is the best strategy IMO.
YES, the chart is turning, at least for today and volume is higher today. The low today was $225.24 which could be the bottom for this 3 month negative run. I’m going to wait a day or two to see where the trend is but I believe Man 6677 and Axelvento are correct; this has been stock manipulation bringing the price down for a new entry point.
I was expecting (hoping) that MRNA would rebound to start the new year. But the drop continues (so far), approaching November’s low of around $225. I expect support at that level but we will soon see. I will hold for the long term even if it drops below $225 but really expect a rebound.
I don’t think Moderna or its investors are too concerned about the ABUS patent. Moderna produced a vaccine with worldwide acceptance and has revenue of $12Billion in the last year. ABUS is still an unprofitable company with a market cap of $526 Million compared to MRNA with $103Billion. Eventually, MRNA will probably settle for a small royalty payment to Arbutus.
Your comments make no sense. Maybe you could find an English class to enroll in. Good Luck.
WTF you talkin bout now? What does Pfizer have to do with Moderna? What “trail” you talkin bout? Do you mean trial? What does CDC have to do with PFE? How is CDC not honest with American people?
What are you talking about mick? You say “CDC is not excepting pcr test first the year”. This statement makes no sense. I apologize for sounding rude if English is not your primary language but you need to communicate in a way that could be understood.
Apparently the CDC has withdrawn it’s own pcr test as many private companies have developed efficient pcr
tests and the CDC’s version in not needed at this time. I note that I was scheduled for international travel this month and all the tests required were mandated to be PCR tests.
It’s okay to believe in God, but he/she has had nothing to say on the subject of COVID as far as I can tell.
Wishing you a happy 2022
Thank you for that thoughtful post. It is always a pleasure to have discussions where we both learn. I’m sorry to hear that you’re missing out on travel, cruises and restaurants. Life’s a bitch, ain’t it?
But this board is about Moderna and I will predict (without any specific dates) that the stock will recover soon and there are more profits to be made in the years to come. I suspect we may see a bottom around $225 but if it goes lower, hold with strong hands. The future is bright.
It looks like the CEO, Stephane Bancel , since Nov 10 has sold 220,667 shares that he owned in direct accounts, leaving him with only 5,801,000 shares. He sold another 60,000 shares in “indirect” accounts, leaving him with over 16,000,000 shares in those accounts.
That’s the “rest of the story,” Supernova 12.
Anti-viral drugs will be used to “treat” COVID infections. They will not “cure” the disease. Think of the decades that we have treated pneumonia and other diseases with antibiotics. Pneumonia, urinary tract infections, strep throat, etc, etc, etc are still with us and will never go away.
The most important tool in the pharmacy is a vaccine and this will continue to be true. Unfortunately, the uninformed and misinformed individuals who refuse vaccination allow the virus to continue to thrive, threatening all of us.
Wrong. The omicron variant is going through the population faster than any prior variant. Lots of vaccinated people are testing positive but they aren’t getting sick. They are NOT in the hospital. The Moderna booster dose of 50 micrograms increases antibody titers by 37X. Those who listen to the misinformation and have not been vaccinated risk severe disease. This is so simple.
Of course, ivermectin and (hydroxy)chloroquine are not listed. They are not vaccines. And there is no credible evidence that either one is effective in treatment of COVID, let alone the specific omicron variant.
Omicron was first detected in South Africa, not Wuhan China.
No, I have reviewed my posts for the last several months and I said on Oct 7 that I expected support at $300 and believed it would rise eventually to $400-500. I did not predict a price for Dec. or Jan 2022. I have been and still am very bullish on the stock. I recognize the evidence supports the benefit of vaccination against COVID and have stated that people who believe the vaccines are killing people are uneducated, stupid people. This is my opinion and we all know what you and your amigos believe.
TMAGA, always wrong but never in doubt. LOL
I believe that investors are slowly starting to understand that the omicron variant will add additional vaccine doses for Moderna and Pfizer/BNTX. Revenue for these companies will be stable for decades because this virus ain’t going away. JMO.
You are right, we won’t see $500 by Christmas. That price was plausible before the last earnings report but now we are stuck in a downward spiral. It won’t last forever as earnings will continue and this will lead to price increase. A good time to buy shares IMO.
I’m not so sure about the flu vaccine data. Morgan Stanley says the market is disappointed, explaining the big drop in stock price today. We wanted to see a superior product, not a “non-inferior”. Of course this is just a phase 1 study, so we know very little at this time. Good news is additional orders for COVID van. Gonna make a lot of money in 2022!
Over 700,000 Americans tried to get “natural immunity” and ended up dead. Great strategy!
Can you identify these “three amigos” you keep referring to?
I am a little tired of all these “buying opportunities”. Very difficult to predict the bottom and any news causes the price to reverse . My bet is that we will see a little more pain before recovery. I would love to catch the bottom with another option. The turnaround could produce rapid profits. In the meantime, I’m holding all my shares for the long term.
It’s hard to find any winners in the stock market today, but there is one big winner so far….BNTX. Hopefully this will mark the beginning of a new rally as investors recognize that long term COVID fears will be positive news for vaccine companies.